These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33844174)

  • 21. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods.
    Soresi M; Cabibi D; Giglio RV; Martorana S; Guercio G; Porcasi R; Terranova A; Lazzaro LA; Emma MR; Augello G; Cervello M; Pantuso G; Montalto G; Giannitrapani L
    Biomed Res Int; 2020; 2020():5023157. PubMed ID: 32420347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes.
    Poynard T; Paradis V; Mullaert J; Deckmyn O; Gault N; Marcault E; Manchon P; Si Mohammed N; Parfait B; Ibberson M; Gautier JF; Boitard C; Czernichow S; Larger E; Drane F; Castille JM; Peta V; Brzustowski A; Terris B; Vallet-Pichard A; Roulot D; Laouénan C; Bedossa P; Castera L; Pol S; Valla D;
    Aliment Pharmacol Ther; 2021 Oct; 54(7):952-966. PubMed ID: 34398492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.
    Danin PE; Anty R; Patouraux S; Raucoules-Aimé M; Gugenheim J; Tran A; Gual P; Iannelli A
    Obes Surg; 2018 Mar; 28(3):735-742. PubMed ID: 28875438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity.
    Coccia F; Testa M; Guarisco G; Bonci E; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
    Endocrine; 2020 Mar; 67(3):569-578. PubMed ID: 31858390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study.
    Theel WB; Boxma-de Klerk BM; Dirksmeier-Harinck F; van Rossum EF; Kanhai DA; Apers JA; van Dalen BM; De Knegt RJ; Neecke B; van der Zwan EM; Grobbee DE; Hankemeier T; Wiebolt J; Castro Cabezas M
    BMJ Open; 2023 Jul; 13(7):e070431. PubMed ID: 37400234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
    López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
    Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.
    Munteanu M; Tiniakos D; Anstee Q; Charlotte F; Marchesini G; Bugianesi E; Trauner M; Romero Gomez M; Oliveira C; Day C; Dufour JF; Bellentani S; Ngo Y; Traussnig S; Perazzo H; Deckmyn O; Bedossa P; Ratziu V; Poynard T;
    Aliment Pharmacol Ther; 2016 Oct; 44(8):877-89. PubMed ID: 27549244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
    Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
    Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study.
    Chaim FDM; Pascoal LB; Chaim FHM; Palma BB; Damázio TA; da Costa LBE; Carvalho R; Cazzo E; Gestic MA; Utrini MP; Milanski M; Chaim EA; Leal RF
    Sci Rep; 2020 May; 10(1):8496. PubMed ID: 32444690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of bariatric surgery in the management of nonalcoholic steatohepatitis.
    Seymour KA; Abdelmalek MF
    Curr Opin Gastroenterol; 2021 May; 37(3):208-215. PubMed ID: 33769376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers reflecting pericellular fibrosis improve together with liver histology after bariatric surgery in early non-alcoholic fatty liver disease.
    Lønsmann I; Steen Pedersen J; Krag A; Hansen T; Karsdal M; Julie Leeming D; Juul Nielsen M; Bendtsen F
    Clin Biochem; 2023 Mar; 113():29-35. PubMed ID: 36574896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HAALT Non-invasive Scoring System for NAFLD in Obesity.
    Sheth H; Bagasrawala S; Shah M; Ansari R; Olithselvan A; Lakdawala M
    Obes Surg; 2019 Aug; 29(8):2562-2570. PubMed ID: 31016455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of bariatric surgery in patients with advanced fibrosis.
    Singh T; Kochhar GS; Goh GB; Schauer P; Brethauer S; Kroh M; Aminian A; Lopez R; Dasarathy S; McCullough AJ
    Int J Obes (Lond); 2017 Mar; 41(3):443-449. PubMed ID: 27881858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery.
    Hatto M; Ivano VK; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2023 May; 33(5):1580-1586. PubMed ID: 37004688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysis.
    Poynard T; Deckmyn O; Peta V; Paradis V; Gautier JF; Brzustowski A; Bedossa P; Castera L; Pol S; Valla D;
    Aliment Pharmacol Ther; 2023 Nov; 58(9):888-902. PubMed ID: 37642160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Ferritin and NAFLD in Patients Undergoing Bariatric Surgery.
    Giacomazzi CB; Tovo CV; Moreira TR; Pase THS; Linhares AB; Coral GP; Rinaldi N; Pioner SR; De Carli LA; Fontes PRO
    Obes Surg; 2022 Aug; 32(8):2658-2663. PubMed ID: 35670949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Benefit of Bariatric Surgery on Histological Features of Metabolic Associated Fatty Liver Disease Assessed Through Noninvasive Methods.
    Meneses D; Olveira A; Corripio R; Méndez MD; Romero M; Calvo-Viñuelas I; González-Pérez-de-Villar N; de-Cos-Blanco AI
    Obes Surg; 2022 Aug; 32(8):2682-2695. PubMed ID: 35697996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.